Skip to main content

ImmunityBio, Inc 10-Q for FY2025 Q2

ImmunityBio, Inc. (IBRX)

10-Q 2025-08-05 For: 2025-06-30
View Original
Added on April 10, 2026

About this 10-Q

ImmunityBio, Inc filed this 10-Q on August 5, 2025, covering the quarter ended June 30, 2025 (FY2025 Q2).

Headline figures

Quarter ended June 30, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$26.43M
up 2423.9% from $1.05M a year earlier
Net loss
$92.56M
compared with a net loss of $134.56M a year earlier
Diluted EPS
-$0.10
compared with -$0.20 a year earlier